Skip Navigation

This Article
Right arrow FREE Full Text (PDF ) Freely available
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (11)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Eldar-Geva, T.
Right arrow Articles by Diamant, Y. Z.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Eldar-Geva, T.
Right arrow Articles by Diamant, Y. Z.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Reproduction, Vol 13, 9-14, Copyright © 1998 by Oxford University Press


ARTICLES

The origin of serum progesterone during the follicular phase of menotropin-stimulated cycles

T Eldar-Geva, EJ Margalioth, B Brooks, N Algur, E Zylber-Haran and YZ Diamant
Department of Obstetrics and Gynaecology, Shaare-Zedek Medical Centre, Jerusalem, Israel.

The study was designed to investigate the source of progesterone secretion during pituitary suppression and ovarian stimulation. It involved 416 women undergoing in-vitro fertilization (IVF) who were treated with gonadotrophin-releasing hormone agonist (GnRHa) and human menopausal gonadotrophin (HMG) (group I), 139 women undergoing ovulation induction with HMG only (group II) and nine women who were diagnosed previously as late-onset adrenal hyperplasia and treated continuously with dexamethasone, in addition to ovulation induction (group III). During HMG treatment, serum oestradiol and progesterone were measured every 1-2 days. If progesterone concentration exceeded 3.0 nmol/l, at least 36 h before human chorionic gonadotrophin (HCG) administration, the patients were prospectively randomized to treatment with dexamethasone or not and the hormones concentrations were measured again 12 h later. Mean age and pretreatment serum concentrations of dehydroepiandrosterone sulphate, androstenedione, testosterone and luteinizing hormone/follicle stimulating hormone (LH/FSH) ratio, were not significantly different in the patients with and without progesterone elevation. Pituitary down-regulation did not reduce the incidence of progesterone elevation (13.9 and 12.2% in groups I and II respectively), while in group III, progesterone concentrations did not increase. After dexamethasone administration a significant decrease in serum progesterone concentration was demonstrated (mean +/- SD, -2.1 +/- 1.4 and -1.6 +/- 1.2 in groups I and II respectively, while in the untreated patients it increased (+1.9 +/- 1.9 and +4.2 +/- 4.8). The increase in serum progesterone concentrations was not accompanied by an increase in cortisol and 11-deoxycortisol but by an increase in LH. After dexamethasone administration the concentrations of cortisol, 11- deoxycortisol and LH significantly decreased. Progesterone concentration was positively correlated with both oestradiol concentration (r = 0.290; P < 0.05) and the number of oocytes retrieved (r = 0.207; P < 0.05). We conclude that at least a part of serum follicular-phase progesterone appears to be of adrenal origin. High oestrogen concentrations (or other ovarian factors) may cause changes in the hypothalamic-pituitary-adrenal axis and in adrenal enzyme activity as a part of the complex 'cross-talk' between the hypothalamic- pituitary-ovarian and the hypothalamic-pituitary-adrenal axes.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Endocr. Rev.Home page
M. Schumacher, R. Guennoun, A. Ghoumari, C. Massaad, F. Robert, M. El-Etr, Y. Akwa, K. Rajkowski, and E.-E. Baulieu
Novel Perspectives for Progesterone in Hormone Replacement Therapy, with Special Reference to the Nervous System
Endocr. Rev., June 1, 2007; 28(4): 387 - 439.
[Abstract] [Full Text] [PDF]


Home page
J AndrolHome page
T. L. Tollner, J. W. Overstreet, M. W. Li, S. A. Meyers, A. I. Yudin, E. R. Salinas, and G. N. Cherr
Lignosulfonic Acid Blocks In Vitro Fertilization of Macaque Oocytes When Sperm Are Treated Either Before or After Capacitation
J Androl, November 1, 2002; 23(6): 889 - 898.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
T. Hemachand, B. Gopalakrishnan, D. M. Salunke, S. M. Totey, and C. Shaha
Sperm plasma-membrane-associated glutathione S-transferases as gamete recognition molecules
J. Cell Sci., May 15, 2002; 115(10): 2053 - 2065.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
C. De Geyter, M. De Geyter, P. R. Huber, E. Nieschlag, and W. Holzgreve
Progesterone serum levels during the follicular phase of the menstrual cycle originate from the crosstalk between the ovaries and the adrenal cortex
Hum. Reprod., April 1, 2002; 17(4): 933 - 939.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
F. Martinez, P.N. Barri, B. Coroleu, R. Tur, T. Sorsa-Leslie, W. J. Harris, N. P. Groome, P. G. Knight, and P. A. Fowler
Women with poor response to IVF have lowered circulating gonadotrophin surge-attenuating factor (GnSAF) bioactivity during spontaneous and stimulated cycles
Hum. Reprod., March 1, 2002; 17(3): 634 - 640.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Michaut, C. N. Tomes, G. De Blas, R. Yunes, and L. S. Mayorga
Calcium-triggered acrosomal exocytosis in human spermatozoa requires the coordinated activation of Rab3A and N-ethylmaleimide-sensitive factor
PNAS, August 17, 2000; (2000) 180206197.
[Abstract] [Full Text]


Home page
Hum ReprodHome page
E. Carmina, F. Gonzalez, A. Vidali, F.Z. Stanczyk, M. Ferin, and R.A. Lobo
The contributions of oestrogen and growth factors to increased adrenal androgen secretion in polycystic ovary syndrome
Hum. Reprod., February 1, 1999; 14(2): 307 - 311.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Michaut, C. N. Tomes, G. De Blas, R. Yunes, and L. S. Mayorga
Calcium-triggered acrosomal exocytosis in human spermatozoa requires the coordinated activation of Rab3A and N-ethylmaleimide-sensitive factor
PNAS, August 29, 2000; 97(18): 9996 - 10001.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.